2021 Virtual KU Hematology and Medical Oncology Review

https://www.kucancercenter.org/

 

2021 Virtual KU Hematology and Medical Oncology Review
A

2021 Advances in Myelofibrosis: Parsaclisib + Ruxolitinib Combinations

By 2021 Virtual KU Hematology and Medical Oncology Review FEATURING Abdulraheem Yacoub
By 2021 Virtual KU Hematology and Medical Oncology Review FEATURING Abdulraheem Yacoub
172 views
July 22, 2021
Comments 0
Login to view comments. Click here to Login
Videos
43:11

2021 Advances in Metastatic Sarcoma: GIST & Ripretinib, Synovial Sar…

2021 Virtual KU Hematology and Medical Oncology Review

B. Van Tine

116 views
25:06

ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpati…

2021 Virtual KU Hematology and Medical Oncology Review

E. Wulff-Burchfield

13 views
30:04

2021 Updates in HNSCC: Expert Overview of Recent Clinical Trials

2021 Virtual KU Hematology and Medical Oncology Review

B. Burtness

169 views
09:13

ASCO 2021 Updates in Head and Neck Cancers: Advanced NPC, HPV-Relate…

2021 Virtual KU Hematology and Medical Oncology Review

B. Burtness

40 views
18:15

KUMC Highlights on mCRC: Recent Data on Changes in the SoC

2021 Virtual KU Hematology and Medical Oncology Review

W. Sun

228 views
06:25

2021 KUMC Metastatic Prostate Cancer Updates: 177Lu-PSMA-617 in mCRP…

2021 Virtual KU Hematology and Medical Oncology Review

S. Abbasi

38 views
08:08

2021 Developments in RCC & UC: Pembro for ccRCC, Sacituzumab Govitec…

2021 Virtual KU Hematology and Medical Oncology Review

S. Abbasi

63 views
15:17

2021 Advances in CML: Prognostic Scores, Treatment Goals, 1L & Beyon…

2021 Virtual KU Hematology and Medical Oncology Review

A. Yacoub

118 views
05:01

2021 Advances in Myelofibrosis: Parsaclisib + Ruxolitinib Combinatio…

2021 Virtual KU Hematology and Medical Oncology Review

A. Yacoub

172 views
10:52

2021 KUMC NDMM Updates: Assessing Current Trials for Treatment, Indu…

2021 Virtual KU Hematology and Medical Oncology Review

A. Abdallah

93 views
07:17

2021 KUMC Updates on Triple R/R MM: Does Ide-Cel Improve Overall Res…

2021 Virtual KU Hematology and Medical Oncology Review

A. Abdallah

15 views
27:42

CAR T-Cell and CRISPR in Hematologic Malignancies: Continuing Revolu…

2021 Virtual KU Hematology and Medical Oncology Review

J. McGuirk

158 views
10:44

ASCO 2021 Highlights on TNBC: Durvalumab + Neoadjuvant Therapy in Ea…

2021 Virtual KU Hematology and Medical Oncology Review

Q. Khan

212 views
08:59

ASCO 2021 Review of the OlympiA Trial for High-Risk EBC: Do Adjuvant…

2021 Virtual KU Hematology and Medical Oncology Review

Q. Khan

291 views
10:17

ASCO 2021 Updates on De-Escalation Strategies in BC: Talazoparib for…

2021 Virtual KU Hematology and Medical Oncology Review

Q. Khan

71 views